- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Walid HABRE
Total 230 results
-
Walid HABRECompletedAnesthesia, General | Ventilation | Respiratory Function Tests | Patient PositioningSwitzerland
-
Walid HABRETerminatedAnalgesia | Sedation | AnxiolysisSwitzerland
-
Walid HABREWithdrawn
-
Walid HABREUniversity Hospital, GenevaTerminatedPain, Postoperative | Postoperative Nausea and Vomiting | Tonsillar BleedingCanada, Switzerland
-
Walid HABRECompletedElectric Impedance | Severe Acute Respiratory Syndrome Coronavirus 2 | Prone PositioningSwitzerland
-
Walid HABRECompleted
-
Ahmed Walid Anwar MuradCompletedUnexplained Infertility
-
Walid Ahmed Ragab AbdelhamidCompleted
-
Walid El-NaggarUnknown
-
Zürcher RehaZentrum WaldUnknown
-
Zürcher RehaZentrum WaldUnknownSleep Disordered BreathingSwitzerland
-
Waid City Hospital, ZurichNot yet recruiting
-
Waid City Hospital, ZurichRecruiting
-
Pierre Fabre MedicamentPierre Fabre Pharma GmbHCompleted
-
Pierre Fabre Medical DevicesCompleted
-
Pierre Fabre Pharma GmbHPierre Fabre Pharma Austria; Pierre Fabre Pharma AGRecruitingMelanoma Stage IV | Melanoma Stage IIIAustria, Germany, Switzerland
-
Abdul Wali Khan University MardanCompleted
-
SRH Wald-Klinikum Gera GmbHCompletedBasal Cell CarcinomaGermany
-
Walid Shaib, MDGlaxoSmithKline; Emory UniversityWithdrawnMetastatic Cancer | Cholangiocarcinoma | HRD
-
Pierre Fabre MedicamentRecruitingMetastatic Melanoma | Melanoma (Skin) | BRAF V600 MutationPortugal
-
Pierre Fabre MedicamentActive, not recruitingAdvanced or Metastatic Solid TumorsFrance, Spain
-
Pierre Fabre MedicamentCompletedBreast Cancer | MetastasesFrance, Ukraine, United Kingdom, Germany, Taiwan, Spain, Belarus, Belgium, Portugal, South Africa, Russian Federation, Austria, Italy, Argentina
-
Pierre Fabre MedicamentCompleted
-
Pierre Fabre MedicamentCompleted
-
Pierre Fabre MedicamentCompletedRecurrent Upper-Respiratory Tract InfectionsItaly, Poland, Romania, Russian Federation, Lithuania
-
Pierre Fabre MedicamentTerminatedIron Deficiency AnemiaBulgaria, Romania
-
Pierre Fabre MedicamentCompletedBladder Transitional Cell Carcinoma Stage IVFrance
-
Pierre Fabre MedicamentCompleted
-
Pierre Fabre MedicamentCompletedIschemic StrokeSpain, France, Switzerland, Germany, Sweden, Italy, Czech Republic, Portugal, Belgium, Hungary, Russian Federation
-
Pierre Fabre DermatologyCompletedInfantile HemangiomaSpain, France, Poland
-
Pierre Fabre MedicamentCompleted
-
Pierre Fabre MedicamentCompletedAcute Sore Throat PainUnited Kingdom, Germany, Latvia, France
-
Pierre Fabre DermatologyCompleted
-
Pierre Fabre MedicamentCompleted
-
Pierre Fabre MedicamentCompleted
-
Pierre Fabre MedicamentNot yet recruiting
-
Pierre Fabre MedicamentTerminatedLocally Advanced or Metastatic Solid TumorsFrance, Spain
-
Pierre Fabre MedicamentActive, not recruiting
-
Pierre Fabre MedicamentCompletedBreast CancerFrance, Poland, Ukraine, United Kingdom, Taiwan, Spain, Belgium, Belarus, Mexico, Bulgaria, India, South Africa, Brazil, Russian Federation, Argentina, Hungary, Italy, Serbia, Switzerland, Czechia, Estonia
-
Pierre Fabre MedicamentCompletedMalignant Neoplasm of BreastChina, Taiwan, Singapore
-
Pierre Fabre MedicamentCompletedRecurrent or Metastatic Head and Neck CarcinomaFrance
-
Pierre Fabre DermatologyWithdrawn
-
Pierre Fabre DermatologyCompletedInfantile HemangiomaGermany, United States, France, Spain, Peru, Australia, Lithuania, Italy, Canada, Czech Republic, Hungary, Mexico, New Zealand, Poland, Romania, Russian Federation
-
Pierre Fabre MedicamentCompletedAtopic DermatitisFrance, Romania, Estonia, Poland, Lithuania
-
Pierre Fabre MedicamentCompletedBenign Prostatic Hyperplasia (BPH)France, Spain, Portugal, Italy
-
Pierre Fabre MedicamentCompletedFibromyalgia SyndromeSpain, Italy, Portugal, France, Czech Republic, Finland, Germany, Norway, Romania, Sweden
-
Pierre Fabre MedicamentCompletedAtopic DermatitisEstonia, France, Lithuania, Poland, Romania